Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
13F holders, Q2 2025 (June 30)6holders −5
4new positions
9sold out
$0.73avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) in their 13F filings, down 5 from Q1 2025. 4 opened new positions and 9 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($3.2M), Fort Baker Capital Management LP ($1.9M) and Exome Asset Management LLC ($1.4M).
- Company
- Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
- CUSIP
- 803607AD2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $4.7M |
| Exits | 9 | $11.5M |
All 13F filers, Q1 2025 → Q2 2025: 6,503,501 shares bought and 12,617,519 shares sold, net −6,114,018 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Add +0.0% | 4,400,000 | $3.2M |
| Fort Baker Capital Management LP | 0.33% | New | 2,500,000 | $1.9M |
| Exome Asset Management LLC | 1.19% | New | 2,000,000 | $1.4M |
| State of Wisconsin Investment Board | 0.00% | New | 2,000,000 | $1.4M |
| Alpine Global Management, LLC | 0.00% | New | 3,500 | $3K |
| Rothschild Investment LLC | 0.00% | No change | 1,000 | $720 |
"% of holder's portfolio" is SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27)'s weight in each manager's 13F, not the share of Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) the manager owns.